Related references
Note: Only part of the references are listed.Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
Arnaud Jeanson et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Phase Ib study of sintilimab in combination with chemotherapy for 1L advanced or metastatic non-small cell lung cancer (NSCLC).
Nong Xu et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors
Hua-fei Chen et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer
Mathieu Grangeon et al.
CLINICAL LUNG CANCER (2019)
Immunotherapeutic approach to a case of advanced hepatoid adenocarcinoma of the lung
Anthony El Khoury et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2019)
Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice
Raffaele Califano et al.
FUTURE ONCOLOGY (2018)
A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression
Victor Basse et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Shrujal Baxi et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Shrujal Baxi et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2017)
Hepatoid adenocarcinoma of the lung metastasizing to the tonsil
Luca Valle et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer
Takehito Shukuya et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Pascale Tomasini et al.
ONCOLOGIST (2016)
Hepatoid adenocarcinoma of the lung
G. -Q. Qian et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
A Novel Approach Using Sorafenib in Alpha Fetoprotein-Producing Hepatoid Adenocarcinoma of the Lung
Tatjana Gavrancic et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes
Cheng Xiao et al.
ONCOLOGY LETTERS (2015)
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature
Diana M. Haninger et al.
MODERN PATHOLOGY (2014)
Hepatoid adenocarcinoma of the lung: Presenting mediastinal metastasis without transfer to the liver
Yi-Qun Che et al.
ONCOLOGY LETTERS (2014)
Primary pulmonary hepatoid carcinoma: Report of a case and review of the literature
Shiou-Fu Lin et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2013)
Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas
Michiya Nishino et al.
MODERN PATHOLOGY (2012)
Hepatoid Pancoast tumor. A case report and review of the literature
Georgios Papatsimpas et al.
LUNG CANCER (2012)
Alpha-fetoprotein-producing lung carcinoma: Report of three cases
K Hiroshima et al.
PATHOLOGY INTERNATIONAL (2002)
Share Paper
